477 Madison Avenue, 3rd Floor
New York, NY 10022

Phone: +1 212 502 3370
Email: info@cap-m.com

Our Team

Mo Shomrat
Mo Shomrat
Mo Shomrat
Senior Analyst

Education

  • Masters of Biomedical Sciences from Rutgers University
  • BS in Chemistry and Mathematics from the College of William and Mary, awarded the Eddie Murphy Scholarship
  • Research Assistant where he designed and constructed novel molecules to better understand cardiovascular disease under Professor Christopher Abelt, a Chancellor Professor and the Chemistry Department Chair

Mo Shomrat is a Senior Analyst at CapM.

Mr. Shomrat is involved in all aspects of mergers and acquisitions advisory in the healthcare, consumer and retail industries.

Prior to joining CapM, Mr. Shomrat served as an Analyst for Fallon Medica Consulting, a management consulting firm advising large pharmaceutical companies. He specialized in gathering quantitative and qualitative data by conducting extensive customer interviews with physicians. He also developed and recommended strategies to help increase sales of novel pharmaceutical products worldwide.

Prior to Fallon Medica Consulting, Mr. Shomrat was a Technology Consultant for TreMonti, a technology consulting firm based in Fairfax, Virginia. His main responsibilities entailed helping biomedical patent holders develop advanced studies to pressure test the validity of biomedical products. He further guided patent holders towards implementing proper marketing steps necessary to gain investment and manufacturing partnerships.

Mr. Shomrat was previously an assistant in the emergency department of Sentara Williamsburg Regional Medical System in Williamsburg, Virginia. His main responsibilities included gathering and verifying pertinent patient information for physicians to develop proper diagnoses and treatment plans. 

Education

  • Masters of Biomedical Sciences from Rutgers University
  • BS in Chemistry and Mathematics from the College of William and Mary, awarded the Eddie Murphy Scholarship
  • Research Assistant where he designed and constructed novel molecules to better understand cardiovascular disease under Professor Christopher Abelt, a Chancellor Professor and the Chemistry Department Chair